Patients may now be initiated on buprenorphine through the use of telepractice in accordance with DEA guidance that is in effect during the state of emergency.
OASAS guidance on the administration and dispensing of narcotic medications to treat opioid use disorders including information on the Data 2000 waiver.
Guidance for OASAS-certified Part 822 Opioid Treatment Programs (OTPs) on nursing practices and Medication-assisted Treatment (MAT) for incarcerated individuals. Issued 9/2019
New York State Department of Health and Office of Alcoholism and Substance Abuse Services best practices for implementing transmucosal buprenorphine for the treatment of opioid use...
A series from the National Institute on Drug Abuse. Offers quick, targeted information on how to get started offering OUD treatment medications and other recovery...
